Skip to content


Shared care monitoring: the impact of COVID-19 and factors associated with resilience

Job information


This repo is not publicly viewable.

Why is this repo private?

In accordance with the Principles of OpenSAFELY we expect all code from all users to be made public.

However, some GitHub repositories may be private during the development stage of a project, which means any links to them from this site will return a '404 Not Found' error unless you are logged in and have the relevant permissions.

Created by
Andrew Brown

This is an OpenSAFELY workspace. It represents a working directory for the 113 - Shared care monitoring: the impact of COVID-19 and factors associated with resilience project on all of the secure services ("backends") supported by OpenSAFELY.

On each backend, the directory includes code from the repository, and the results of running it against real data ("jobs"). Researchers can request jobs are run from this page.

Workspace purpose

To evaluate whether the COVID-19 pandemic affected the completion of shared care drug monitoring. It also considers whether any such effect was associated with other variables, such as patient demographics or comorbidities. The analysis covers all patients registered with a GP practice aged 18 years and over, who are currently prescribed currently prescribed Azathioprine, Methotrexate, or Leflunomide. Understanding the impact of COVID-19 on monitoring lays the foundation for further analysis of the health impact and recovery planning, and in the longer-term an analysis of whether current monitoring recommendations remain appropriate. Furthermore, understanding which factors underpin variance in resilience to deterioration in monitoring adherence may be valuable learning points, with a view to increasing the resilience of the population overall, and reducing health inequalities between the least and most resilient segments.